Loading...
XKRX024720
Market cap158mUSD
Jan 03, Last price  
6,800.00KRW
1D
1.04%
1Q
-11.57%
Jan 2017
-79.82%
Name

Kolmar Korea Holdings Co Ltd

Chart & Performance

D1W1MN
XKRX:024720 chart
P/E
—
P/S
0.37
EPS
—
Div Yield, %
7.68%
Shrs. gr., 5y
13.23%
Rev. gr., 5y
2.56%
Revenues
637.27b
-1.94%
85,262,922,000125,587,928,000153,543,293,000188,064,645,000270,992,597,000324,517,641,240106,625,624,260132,262,221,010222,474,428,770299,567,094,920330,438,588,910490,565,263,210561,696,121,310593,433,802,380675,480,246,340674,006,002,130649,879,568,750637,274,322,590
Net income
-3.72b
L
8,259,696,0005,779,183,0005,578,004,00011,736,504,00011,228,895,00018,708,505,00019,763,903,7508,766,407,52019,513,981,870-742,369,50036,641,942,55028,032,100,06090,232,664,18072,236,250,990113,135,323,43058,643,455,89013,023,596,370-3,715,523,710
CFO
43.90b
P
4,554,246,0006,176,510,00011,829,878,00011,746,555,00012,932,321,00015,609,991,90018,257,937,15013,425,256,63029,219,839,92026,535,547,42025,257,525,88068,303,392,34038,455,787,30084,102,124,99083,326,142,69015,327,485,530-11,348,009,54043,903,567,280
Dividend
Dec 27, 2023180 KRW/sh
Earnings
Feb 26, 2025

Profile

Kolmar Korea Holdings Co., Ltd. manufactures and sells cosmetics, pharmaceuticals, and health functional foods in South Korea and internationally. It offers skin care, makeup, hair care, body care, and baby products, as well as functional cosmetics and perfumes. The company also provides quasi-drugs and health supplements. Kolmar Korea Holdings Co., Ltd. was founded in 1990 and is headquartered in Sejong City, South Korea.
URL
http://www.kolmar.co.kr
IPO date
Apr 09, 2002
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
637,274,323
-1.94%
649,879,569
-3.58%
Cost of revenue
567,596,720
563,372,122
Unusual Expense (Income)
NOPBT
69,677,603
86,507,447
NOPBT Margin
10.93%
13.31%
Operating Taxes
2,026,855
23,372,512
Tax Rate
2.91%
27.02%
NOPAT
67,650,748
63,134,935
Net income
(3,715,524)
-128.53%
13,023,596
-77.79%
Dividends
(17,920,815)
(10,971,077)
Dividend yield
Proceeds from repurchase of equity
(14,138,268)
BB yield
Debt
Debt current
215,662,840
215,752,410
Long-term debt
129,159,271
59,301,713
Deferred revenue
Other long-term liabilities
9,637,661
6,478,404
Net debt
(403,079,222)
(305,689,036)
Cash flow
Cash from operating activities
43,903,567
(11,348,010)
CAPEX
(88,472,569)
(37,471,790)
Cash from investing activities
(80,247,493)
(45,014,901)
Cash from financing activities
(12,686,372)
50,869,631
FCF
(9,623,641)
39,293,042
Balance
Cash
128,799,127
195,155,066
Long term investments
619,102,205
385,588,094
Excess cash
716,037,616
548,249,181
Stockholders' equity
250,798,827
848,115,092
Invested Capital
917,310,979
571,776,191
ROIC
9.09%
11.70%
ROCE
5.89%
7.61%
EV
Common stock shares outstanding
36,797
36,958
Price
Market cap
EV
EBITDA
90,134,776
107,089,984
EV/EBITDA
Interest
13,076,442
11,603,791
Interest/NOPBT
18.77%
13.41%